*Sun Pharmaceutical* disclosed a good rise in consolidated net profit for the quarter ended December 2008.
During the quarter, the net profit after tax & minority interest of the company rose 28.36% over prior year period to Rs 4,086.40 million from Rs 3,183.50 million in the same quarter last year. Consolidated total income increased 14.78% from Rs 8,082.80 million for the quarter ended Dec. 31, 2007 to Rs 9277.60 million for the quarter ended Dec. 31, 2008. *Standalone results* The company reported a steep drop in standalone net profit for the quarter ended December 2008. During the quarter, the profit of the company declined 25.80% to Rs 2,566.80 million from Rs 3,459.30 million in the same quarter last year. Net sales for the quarter rose 17.58% to Rs 8,629.30 million, while total income for the quarter fell 9.74% to Rs 8,667.80 million, when compared with the prior year period. The company posted earnings of Rs 12.40 a share during the quarter, registering 27.91% decline over previous year period. *Quarterly Results - Standalone (Rs in mn)* *As at* *Dec - 08* *Dec - 07* *%Change* *Net Sales* 8,629.30 7,339.10 17.58 *Net Profit* 2,566.80 3,459.30 (25.80) *Basic EPS* 12.40 17.20 (27.91) --~--~---------~--~----~------------~-------~--~----~ You received this message because you are subscribed to the Google Groups "Kences1" group. To post to this group, send email to [email protected] To unsubscribe from this group, send email to [email protected] For more options, visit this group at http://groups.google.com/group/kences1?hl=en -~----------~----~----~----~------~----~------~--~---
